Advertisement
Screener

Cartesian Therapeutics, Inc. (RNAC) Public Float

2.8 / 5 stars · 68/120 Roast Me

Cartesian Therapeutics, Inc. Public Float

Cartesian Therapeutics, Inc. (RNAC) had Public Float of $108.74 million as of 2025-06-30, per its 10-K filed 2026-03-09.

Financial Statements › Notes › Cover Page

dei:EntityPublicFloat · last filed 2026-03-09

  • 2025-06-30: Entity Public Float $108.74M.
  • 2024-06-28: Entity Public Float $193.90M.
  • 2023-06-30: Entity Public Float $128.81M.
  • 2022-06-30: Entity Public Float $149.71M.
Period endEntity Public Float
2025-06-30$108.74M
10-K · filed 2026-03-09
2024-06-28$193.90M
10-K · filed 2025-03-13
2023-06-30$128.81M
10-K · filed 2024-03-07
2022-06-30$149.71M
10-K · filed 2023-03-02
2021-06-30$366.84M
10-K/A · filed 2022-04-28
2020-06-30$247.96M
10-K · filed 2021-03-12
2019-06-30$58.50M
10-K · filed 2020-03-12
2018-06-29$197.70M
10-K · filed 2019-03-15
2017-06-30$287.78M
10-K · filed 2018-03-15
2016-06-30$152.37M
10-K · filed 2017-03-28

Similar stocks

Stock NameCountryMarket CapPE Ratio
Keros Therapeutics, Inc. (KROS)United States$0.229B-2.55
SIGA TECHNOLOGIES INC (SIGA)United States$0.234B-93.33
NATURES SUNSHINE PRODUCTS INC (NATR)United States$0.228B20.51
Sionna Therapeutics, Inc. (SION)United States$0.236B-20.37
Camp4 Therapeutics Corp (CAMP)United States$0.240B-2.12
Whitehawk Therapeutics, Inc. (WHWK)United States$0.221B
MACROGENICS INC (MGNX)United States$0.242B-20.11
Cue Biopharma, Inc. (CUE)United States$0.243B-1.01
Entrada Therapeutics, Inc. (TRDA)United States$0.243B-1.73
Eledon Pharmaceuticals, Inc. (ELDN)United States$0.219B-3.23